![](https://investorshub.advfn.com/uicon/576692.png?cb=1483181234)
Thursday, December 10, 2020 6:31:15 AM
Recent GLSI News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:33:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 10:05:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 10:05:18 AM
- Greenwich LifeSciences Provides Update on Expansion of Flamingo-01 into Spain • GlobeNewswire Inc. • 08/01/2024 10:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/24/2024 10:05:14 AM
- Greenwich LifeSciences Set to Join Russell 2000 Index Again • GlobeNewswire Inc. • 06/26/2024 11:33:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 10:20:29 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 10:10:09 AM
- Greenwich LifeSciences Announces $2.5 Million Private Placement • GlobeNewswire Inc. • 06/14/2024 10:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/20/2024 08:30:42 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 08:30:42 PM
- Greenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025 • GlobeNewswire Inc. • 03/13/2024 10:00:00 AM
- Greenwich LifeSciences Partners with GEICAM in Spain & Conducts First Site Initiation Visits in Europe • GlobeNewswire Inc. • 03/12/2024 10:00:00 AM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 03/07/2024 02:41:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 11:05:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 11:05:19 AM
- Greenwich LifeSciences Flamingo-01 Phase III Clinical Trial Approved to Expand into Five Largest European Countries • GlobeNewswire Inc. • 02/27/2024 11:00:00 AM
- Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European Regulators • GlobeNewswire Inc. • 02/22/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:05:12 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 09:15:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 11:04:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:10:47 PM
- Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01 • GlobeNewswire Inc. • 02/14/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 09:15:23 PM
- Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2024 • GlobeNewswire Inc. • 11/21/2023 11:00:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM